Welcome to LookChem.com Sign In|Join Free

CAS

  • or

79642-50-5

Post Buying Request

79642-50-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79642-50-5 Usage

Description

Disuccinimidyl glutarate (DSG) is a homobifunctional crosslinking agent that contains amine-reactive N-hydroxysuccinimide (NHS) ester groups at each end. DSG is membrane-permeable and non-cleavable. DSG can be combined with formaldehyde fixation to improve the detection of specific protein-DNA complexes.

Characteristics

Features of disuccinimidyl glutarate:Reactive groups: NHS ester (both ends)Reactive towards: amino groups (primary amines)Non-cleavableWater-insoluble (dissolve first in DMF or DMSO)Membrane-permeable, allowing for intracellular crosslinkingCan increase crosslinking efficiency compared to DSS in some applications

Uses

Disuccinimidyl glutarate is used as a membrane-soluble, amine-reactive N-hydroxysuccinamide ester-based homobifunctional crosslinking reagent. It is a homobifunctionla cross-linking reagent, for ex. isolation of the insulin receptor.

Check Digit Verification of cas no

The CAS Registry Mumber 79642-50-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,6,4 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 79642-50:
(7*7)+(6*9)+(5*6)+(4*4)+(3*2)+(2*5)+(1*0)=165
165 % 10 = 5
So 79642-50-5 is a valid CAS Registry Number.

79642-50-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H58208)  Disuccinimidyl glutarate, 97%   

  • 79642-50-5

  • 100mg

  • 1300.0CNY

  • Detail
  • Alfa Aesar

  • (H58208)  Disuccinimidyl glutarate, 97%   

  • 79642-50-5

  • 500mg

  • 5197.0CNY

  • Detail

79642-50-5Downstream Products

79642-50-5Relevant articles and documents

MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

-

Paragraph 0264, (2017/01/02)

Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.

3D small-molecule microarrays

Marsden, David M.,Nicholson, Rebecca L.,Ladlow, Mark,Spring, David R.

supporting information; experimental part, p. 7107 - 7109 (2010/03/25)

A PEG based 3D hydrogel slide was developed specifically for small-molecule microarraying purposes, which displayed improved loading capacity, signal sensitivity and spot morphology compared with a commercially available slide and comparative 2D slide. The Royal Society of Chemistry 2009.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 79642-50-5